{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:31:15Z","timestamp":1788208275909,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to investigate the hospitalisation rates and the reasons for hospitalisation in patients with polymyalgia rheumatica (PMR). Furthermore, it aimed to clarify the impact of a newly established Fast Track Clinic (FTC) approach on hospitalisation rates in connection with PMR diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients diagnosed with PMR at South-West Jutland Hospital, Denmark, between 2013 and 2018 were included retrospectively. Only patients fulfilling the 2012 EULAR\/ACR classification criteria were included in our cohort. An FTC for patients suspected of having PMR was established in the rheumatologic department of South-West Jutland Hospital in January 2018.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Over 6 years (2013 to 2017), 254 patients were diagnosed with PMR, 56 of them while hospitalised. Hospitalised patients were more likely to have a higher initial CRP mean\u2009\u00b1\u2009standard deviation (SD) 99.53\u2009\u00b1\u200959.36 vs 45.82\u2009\u00b1\u200936.96\u2009mg\/lt (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009\u00a00.0001) and a shorter duration of symptoms (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0018). After implementing the FTC, a significant decrease in hospitalisation rates (from 20.4% to 3,5%) and inpatient days of care (mean\u2009\u00b1\u2009SD 4.15\u2009\u00b1\u20093.1 vs 1\u2009\u00b1\u20090) were observed. No differences between the two groups were observed regarding clinical symptoms, laboratory values and initial prednisolone dose.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A substantial number of patients are hospitalised in connection with the PMR diagnosis. The FTC approach can decrease the hospitalisation rates significantly among these patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Retrospectively registered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41927-021-00210-6","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T20:39:54Z","timestamp":1633379994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The fast-track outpatient clinic significantly decreases hospitalisation rates among polymyalgia rheumatica patients"],"prefix":"10.1186","volume":"5","author":[{"given":"Stavros","family":"Chrysidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip Rask","family":"Lage-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoletta","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas P.","family":"Diamantopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"issue":"22","key":"210_CR1","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1001\/jama.2016.5444","volume":"315","author":"F Buttgereit","year":"2016","unstructured":"Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia Rheumatica and Giant cell arteritis: a systematic review. JAMA. 2016;315(22):2442\u201358. https:\/\/doi.org\/10.1001\/jama.2016.5444.","journal-title":"JAMA"},{"issue":"10","key":"210_CR2","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1002\/art.24459","volume":"61","author":"MA Gonzalez-Gay","year":"2009","unstructured":"Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009;61(10):1454\u201361. https:\/\/doi.org\/10.1002\/art.24459.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"210_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/art.1780300308","volume":"30","author":"P Boesen","year":"1987","unstructured":"Boesen P, Sorensen SF, Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982-1985. Arthritis Rheum. 1987;30(3):294\u20139.","journal-title":"Arthritis Rheum"},{"issue":"610","key":"210_CR4","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.3399\/bjgp13X667231","volume":"63","author":"T Helliwell","year":"2013","unstructured":"Helliwell T, Hider SL, Mallen CD. Polymyalgia rheumatica: diagnosis, prescribing, and monitoring in general practice. Br J Gen Pract. 2013;63(610):e361\u20136. https:\/\/doi.org\/10.3399\/bjgp13X667231.","journal-title":"Br J Gen Pract"},{"issue":"3","key":"210_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/art.21160","volume":"53","author":"HM Kremers","year":"2005","unstructured":"Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE. Use of physician services in a population-based cohort of patients with polymyalgia rheumatica over the course of their disease. Arthritis Rheum. 2005;53(3):395\u2013403. https:\/\/doi.org\/10.1002\/art.21160.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"210_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4081\/reumatismo.2018.1070","volume":"70","author":"BD Nielsen","year":"2018","unstructured":"Nielsen BD, Dasgupta B. Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica. Reumatismo. 2018;70(1):1\u20139. https:\/\/doi.org\/10.4081\/reumatismo.2018.1070.","journal-title":"Reumatismo"},{"issue":"9","key":"210_CR7","first-page":"1739","volume":"24","author":"JT Gran","year":"1997","unstructured":"Gran JT, Myklebust G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, South Norway: a prospective study 1987-94. J Rheumatol. 1997;24(9):1739\u201343.","journal-title":"J Rheumatol"},{"issue":"676","key":"210_CR8","doi-asserted-by":"publisher","first-page":"e783","DOI":"10.3399\/bjgp18X699557","volume":"68","author":"T Helliwell","year":"2018","unstructured":"Helliwell T, Muller S, Hider SL, Zwierska I, Lawton S, Richardson J, et al. Challenges of diagnosing and managing polymyalgia rheumatica: a multi-methods study in UK general practice. Br J Gen Pract. 2018;68(676):e783\u201393. https:\/\/doi.org\/10.3399\/bjgp18X699557.","journal-title":"Br J Gen Pract"},{"issue":"4","key":"210_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3899\/jrheum.110977","volume":"39","author":"EL Matteson","year":"2012","unstructured":"Matteson EL, et al. Patient-reported outcomes in polymyalgia rheumatica. J Rheumatol. 2012;39(4):795\u2013803. https:\/\/doi.org\/10.3899\/jrheum.110977.","journal-title":"J Rheumatol"},{"issue":"5","key":"210_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/art.22777","volume":"57","author":"A Hutchings","year":"2007","unstructured":"Hutchings A, Hollywood J, Lamping DL, Pease CT, Chakravarty K, Silverman B, et al. Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica. Arthritis Rheum. 2007;57(5):803\u20139. https:\/\/doi.org\/10.1002\/art.22777.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"210_CR11","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1093\/rheumatology\/keq040","volume":"49","author":"J Ji","year":"2010","unstructured":"Ji J, Liu X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in patients hospitalized hospitalised with polymyalgia rheumatica and giant cell arteritis: a follow-up study in Sweden. Rheumatology (Oxford). 2010;49(6):1158\u201363. https:\/\/doi.org\/10.1093\/rheumatology\/keq040.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"210_CR12","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s00296-014-3034-y","volume":"34","author":"E Dalkilic","year":"2014","unstructured":"Dalkilic E, et al. The process from symptom onset to rheumatology clinic in polymyalgia rheumatica. Rheumatol Int. 2014;34(11):1589\u201392. https:\/\/doi.org\/10.1007\/s00296-014-3034-y.","journal-title":"Rheumatol Int"},{"issue":"4","key":"210_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4997\/JRCPE.2012.413","volume":"42","author":"V Quick","year":"2012","unstructured":"Quick V, Kirwan JR. Our approach to the diagnosis and treatment of polymyalgia rheumatica and giant cell (temporal) arteritis. J R Coll Physicians Edinb. 2012;42(4):341\u20139. https:\/\/doi.org\/10.4997\/JRCPE.2012.413.","journal-title":"J R Coll Physicians Edinb"},{"issue":"2 Suppl 89","key":"210_CR14","first-page":"S103","volume":"33","author":"P Patil","year":"2015","unstructured":"Patil P, et al. Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study. Clin Exp Rheumatol. 2015;33(2 Suppl 89):S103\u20136.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"210_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/rheumatology\/kev289","volume":"55","author":"AP Diamantopoulos","year":"2016","unstructured":"Diamantopoulos AP, Haugeberg G, Lindland A, Myklebust G. The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis? Rheumatology (Oxford). 2016;55(1):66\u201370. https:\/\/doi.org\/10.1093\/rheumatology\/kev289.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"210_CR16","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","volume":"71","author":"B Dasgupta","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European league against rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2012;71(4):484\u201392. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200329.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"210_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"210_CR18","unstructured":"Available from: https:\/\/sundhedsdatastyrelsen.dk\/da\/afregning-og-finansiering\/takster-drg\/takster-2019."},{"issue":"1","key":"210_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/annrheumdis-2017-211687","volume":"77","author":"V Schonau","year":"2018","unstructured":"Schonau V, et al. The value of (18) F-FDG-PET\/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study. Ann Rheum Dis. 2018;77(1):70\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211687.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"210_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1053\/sarh.2000.8366","volume":"30","author":"F Cantini","year":"2000","unstructured":"Cantini F, Salvarani C, Olivieri I, Macchioni L, Ranzi A, Niccoli L, et al. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study. Semin Arthritis Rheum. 2000;30(1):17\u201324. https:\/\/doi.org\/10.1053\/sarh.2000.8366.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"210_CR21","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/art.1780390220","volume":"39","author":"SM Helfgott","year":"1996","unstructured":"Helfgott SM, Kieval RI. Polymyalgia rheumatica in patients with a normal erythrocyte sedimentation rate. Arthritis Rheum. 1996;39(2):304\u20137. https:\/\/doi.org\/10.1002\/art.1780390220.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"210_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.23176","volume":"58","author":"RC Lawrence","year":"2008","unstructured":"Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II Arthritis Rheum. 2008;58(1):26\u201335. https:\/\/doi.org\/10.1002\/art.23176.","journal-title":"Part II Arthritis Rheum"},{"issue":"8","key":"210_CR23","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1136\/ard.2005.046912","volume":"65","author":"L Smeeth","year":"2006","unstructured":"Smeeth L, Cook C, Hall AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001. Ann Rheum Dis. 2006;65(8):1093\u20138. https:\/\/doi.org\/10.1136\/ard.2005.046912.","journal-title":"Ann Rheum Dis"},{"issue":"10076","key":"210_CR24","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/S0140-6736(16)32381-9","volume":"389","author":"V Kontis","year":"2017","unstructured":"Kontis V, Bennett JE, Mathers CD, Li G, Foreman K, Ezzati M. Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. Lancet. 2017;389(10076):1323\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(16)32381-9.","journal-title":"Lancet"},{"issue":"8","key":"210_CR25","first-page":"1335","volume":"20","author":"HJ Haga","year":"1993","unstructured":"Haga HJ, Eide GE, Brun J, Johansen A, Langmark F. Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol. 1993;20(8):1335\u20139.","journal-title":"J Rheumatol"},{"issue":"10","key":"210_CR26","first-page":"2143","volume":"29","author":"G Myklebust","year":"2002","unstructured":"Myklebust G, Wilsgaard T, Jacobsen BK, Gran JT. No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls. J Rheumatol. 2002;29(10):2143\u20137.","journal-title":"J Rheumatol"},{"issue":"10","key":"210_CR27","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1136\/annrheumdis-2013-203465","volume":"73","author":"S Muller","year":"2014","unstructured":"Muller S, Hider SL, Belcher J, Helliwell T, Mallen CD. Is cancer associated with polymyalgia rheumatica? A cohort study in the general practice research database. Ann Rheum Dis. 2014;73(10):1769\u201373. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203465.","journal-title":"Ann Rheum Dis"},{"key":"210_CR28","doi-asserted-by":"crossref","unstructured":"Pfeifer EC, Crowson CS, Major BT, Matteson EL. Polymyalgia Rheumatica and its Association with Cancer. Rheumatology (Sunnyvale). 2015;Suppl 6:003. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4681516.","DOI":"10.4172\/2161-1149.S6-003"},{"issue":"4","key":"210_CR29","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/rheumatology\/kew273","volume":"56","author":"C Dejaco","year":"2017","unstructured":"Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology (Oxford). 2017;56(4):506\u201315. https:\/\/doi.org\/10.1093\/rheumatology\/kew273.","journal-title":"Rheumatology (Oxford)"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-021-00210-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-021-00210-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-021-00210-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T21:21:16Z","timestamp":1673385676000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcrheumatol.biomedcentral.com\/articles\/10.1186\/s41927-021-00210-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["210"],"URL":"https:\/\/doi.org\/10.1186\/s41927-021-00210-6","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]},"assertion":[{"value":"10 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"1. Permission to access the data was obtained from the Danish Health Authority with number: 3\u20133013-2338\/1.2. Permission by the South-West Hospital\u2019s Data Agency in Esbjerg: \u201cRegion Syddanmark 1779\u201d was obtained.3 The ethics committee of the South Denmark Region Committees on Health Research Ethics reviewed the study and concluded that the study does not fall under the scope of the Medical Research Involving Human Subjects Act and that written informed consent was not mandatory. Further information and documentation to support this are available to the editor on request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}